top of page
Search


COVID-19 to reshape R&D investments toward infectious diseases
Infectious diseases have been largely forgotten by Pharma R&D and investors, as chronic diseases, cancer and rare diseases gave better...

Laurent DECORY
Jan 4, 20211 min read
Â
Â
Â


Covid-19 vaccine approval to massively accelerate mRNA innovation
With COVID-19 vaccine authorization, BioNTech SE and Pfizer open the door for massive acceleration of mRNA innovation, in...

Laurent DECORY
Dec 16, 20201 min read
Â
Â
Â


Moderna Covid-19 vaccine: 94% efficacy with easier storage
Following Pfizer-BioNTech 90% efficacy announcement, Moderna data show 94% efficacy against Covid-19, while allowing easier storage: long...

Laurent DECORY
Dec 16, 20201 min read
Â
Â
Â
bottom of page